These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2364986)

  • 1. Antagonism of [3H]zacopride binding to 5-HT3 recognition sites by its (R) and (S) enantiomers.
    Pinkus LM; Sarbin NS; Gordon JC; Munson HR
    Eur J Pharmacol; 1990 Apr; 179(1-2):231-5. PubMed ID: 2364986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]zacopride binding to 5-hydroxytryptamine3 sites on partially purified rabbit enteric neuronal membranes.
    Gordon JC; Barefoot DS; Sarbin NS; Pinkus LM
    J Pharmacol Exp Ther; 1989 Dec; 251(3):962-8. PubMed ID: 2600824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of [3H]zacopride with 5-HT3 binding sites.
    Pinkus LM; Sarbin NS; Barefoot DS; Gordon JC
    Eur J Pharmacol; 1989 Sep; 168(3):355-62. PubMed ID: 2583241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues.
    Kidd FJ; Levy JC; Nielsen M; Hamon M; Gozlan H
    Eur J Pharmacol; 1993 Sep; 247(1):45-56. PubMed ID: 8258360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nerve growth factor induces 5-HT3 recognition sites in rat pheochromocytoma (PC12) cells.
    Gordon JC; Rowland HC
    Life Sci; 1990; 46(20):1435-42. PubMed ID: 2345488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]zacopride: ligand for the identification of 5-HT3 recognition sites.
    Barnes NM; Costall B; Naylor RJ
    J Pharm Pharmacol; 1988 Aug; 40(8):548-51. PubMed ID: 2907008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron.
    Barnes JM; Barnes NM
    Biochem Pharmacol; 1993 May; 45(10):2155-8. PubMed ID: 8390263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical properties of serotonin 5-HT3 binding sites solubilized from membranes of NG 108-15 neuroblastoma-glioma cells.
    Miquel MC; Emerit MB; Bolaños FJ; Schechter LE; Gozlan H; Hamon M
    J Neurochem; 1990 Nov; 55(5):1526-36. PubMed ID: 2213008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubilization of a 5-HT3 binding site from rabbit small bowel muscularis membranes.
    Gordon JC; Sarbin NS; Barefoot DS; Pinkus LM
    Eur J Pharmacol; 1990 Jun; 188(6):313-9. PubMed ID: 2373145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat.
    Barnes JM; Barnes NM; Champaneria S; Costall B; Naylor RJ
    Neuropharmacology; 1990 Nov; 29(11):1037-45. PubMed ID: 2087255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of S(-)-zacopride-insensitive [125I]R(+)-zacopride binding sites in the rat brain and peripheral tissues.
    Ge J; Barnes JM; Towers P; Barnes NM
    Eur J Pharmacol; 1997 Aug; 332(3):307-12. PubMed ID: 9300265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The (S)-isomer of [3H]zacopride labels 5-HT3 receptors with high affinity in rat brain.
    Waeber C; Pinkus LM; Palacios JM
    Eur J Pharmacol; 1990 Jun; 181(3):283-7. PubMed ID: 2384135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of stereoisomers of zacopride to analyze actions of 5-hydroxytryptamine on enteric neurons.
    Wade PR; Mawe GM; Branchek TA; Gershon MD
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G80-90. PubMed ID: 1987811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells.
    Bolaños FJ; Schechter LE; Miquel MC; Emerit MB; Rumigny JF; Hamon M; Gozlan H
    Biochem Pharmacol; 1990 Oct; 40(7):1541-50. PubMed ID: 2222509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand [3H]meta-chlorophenylbiguanide.
    Steward LJ; West KE; Kilpatrick GJ; Barnes NM
    Eur J Pharmacol; 1993 Oct; 243(1):13-8. PubMed ID: 8253120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zacopride and its optical isomers produce stereoselective antagonism of a 2-methylserotonin discriminative stimulus.
    Young R; Glennon RA
    Eur J Pharmacol; 1992 Feb; 212(1):117-9. PubMed ID: 1555633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potent 5-HT3 receptor antagonist (R)-zacopride labels an additional high affinity site in the central nervous system.
    Kidd E; Bouchelet de Vendegies I; Levy JC; Hamon M; Gozlan H
    Eur J Pharmacol; 1992 Jan; 211(1):133-6. PubMed ID: 1618262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zacopride, a potent 5-HT3 antagonist.
    Smith WW; Sancilio LF; Owera-Atepo JB; Naylor RJ; Lambert L
    J Pharm Pharmacol; 1988 Apr; 40(4):301-2. PubMed ID: 2900319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of 5-hydroxytryptamine3 receptors in murine brain and ileum using the novel radioligand [3H]RS-42358-197: evidence for receptor heterogeneity.
    Bonhaus DW; Wong EH; Stefanich E; Kunysz EA; Eglen RM
    J Neurochem; 1993 Nov; 61(5):1927-32. PubMed ID: 8229003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.